Stay updated on HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:10:43.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The 403 Forbidden page remains unchanged in substance; its footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:07:35.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The study page for NCT04337658 now renders a 403 Forbidden error instead of displaying the study details, blocking access to the record; this is accompanied by a minimal header/footer indicating an access-denied page rather than the full study information.
    Difference
    21%
    Check dated 2026-09-20T19:46:42.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a new site revision label: Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects an internal frontend update rather than a substantive content change.
    Difference
    0.1%
    Check dated 2026-08-30T12:08:51.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The sponsor institution name is updated to Second Affiliated Hospital, Zhejiang University, School of Medicine to reflect the proper organizational naming. The page revision tag is updated to v3.6.5, changing the documented version of the study record.
    Difference
    0.3%
    Check dated 2026-08-08T23:14:00.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.4, indicating a minor metadata update to the page.
    Difference
    0.0%
    Check dated 2026-07-25T12:56:28.000Z thumbnail image

Stay in the know with updates to HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.